News from cell therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 13, 2014, 07:13 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Financial Results for the Third Quarter of 2014 and Provides Corporate Update

 BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced...

Nov 05, 2014, 08:45 ET

BrainStorm Cell Therapeutics to Report Third Quarter 2014 Financial Results on Thursday, November 13

 BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today...

Oct 07, 2014, 07:07 ET
BrainStorm Cell Therapeutics (PRNewsFoto/BrainStorm Cell Therapeutics Inc)

FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Oct 06, 2014, 09:00 ET

BrainStorm Reports Last Patient Visit in Phase 2a ALS Study

BrainStorm Cell Therapeutics (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced...

May 30, 2014, 01:30 ET
CTI BioPharma Corp. Logo (PRNewsFoto/Cell Therapeutics, Inc.)

Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp.

 Cell Therapeutics, Inc. (CTI or the Company) (NASDAQ and MTA: CTIC), a biopharmaceutical company focused on acquiring, developing and bringing...

May 29, 2014, 01:30 ET

Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that management will present at the Jefferies 2014 Global Healthcare...

Apr 29, 2014, 16:01 ET

Cell Therapeutics Reports First Quarter 2014 Financial Results

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2014. "In the first...

Apr 29, 2014, 01:30 ET

PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for...

Apr 22, 2014, 01:30 ET

Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter 2014 financial results on Tuesday,...

Mar 05, 2014, 01:30 ET

Cell Therapeutics to Present at the 26th Annual ROTH Conference

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that management will present at the ROTH Capital Partners 26th Annual...

Mar 04, 2014, 16:00 ET

Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the fourth quarter and full year ended December 31, 2013....

Mar 03, 2014, 01:30 ET

CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will...

Feb 27, 2014, 01:30 ET

NICE Publishes Final Guidance on PIXUVRI® (pixantrone)

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that the National Institute for Health and Care Excellence (NICE), the...

Feb 25, 2014, 01:30 ET

Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its fourth quarter and full year 2013 financial...

Feb 03, 2014, 01:30 ET

Cell Therapeutics Appoints Karen Ignagni to Board of Directors

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that Karen Ignagni has been appointed a Director of CTI, effective...

Jan 30, 2014, 01:30 ET

CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of an international cooperative group Phase 2 clinical trial of...

Jan 28, 2014, 01:30 ET

Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that the Gynecologic Oncology Group (GOG) informed CTI that it has...

Jan 14, 2014, 01:30 ET

Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced a corporate update for 2014 in addition to an overview of recent progress...

Jan 13, 2014, 01:30 ET

Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds

 Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that it has reached an agreement with Novartis to reacquire rights to two...

Jan 06, 2014, 01:30 ET

PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that the National Institute for Health and Care Excellence (NICE), the...